Early Phase 1 Refractory Solid Tumor Clinical Trials

4 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–4 of 4 trials

Recruiting

Early Phase 1

Personalized KSX01-TCRT in Patients With Advanced Solid Tumors

Refractory Solid TumorsRelapsed Solid Tumors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences12 enrolled1 locationNCT06150365

Recruiting

Early Phase 1

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

Advanced Refractory Solid TumorsSubjects Considered Likely to Respond to CB-03-10

Cosmo Technologies Ltd90 enrolled6 locationsNCT03863145

Recruiting

Early Phase 1

KSH01-TCRT Solid Tumors

Refractory Solid TumorsRelapsed Solid TumorsTCR-T Cells

TCRx Therapeutics Co.Ltd50 enrolled1 locationNCT05539833

Recruiting

Early Phase 1

KSX01-TCRT Injection Project in Solid Tumors

Refractory Solid TumorsRelapsed Solid TumorsTCR-T Cells

TCRx Therapeutics Co.Ltd50 enrolled1 locationNCT05811975